ILD-PRO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Jan 2026)
What this means for you
Registered since 23 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88141447
- Registration number
- 6086392
- Mark type
- Design + words
- Filed
- 03 Oct 2018
- Published for opposition
- 05 Mar 2019
- Registered
- 23 Jun 2020
- Attorney of record
- Scott J. Major
Goods and services
- Class 035 — Advertising and business services: Maintaining a registry of patients with interstitial lung diseases; promoting awareness of interstitial lung diseases, their symptoms, prevention and treatment, and promoting awareness of biomarker testing therefor
- Class 044 — Medical, beauty and agricultural services: Providing medical and pharmaceutical information regarding interstitial lung diseases, their symptoms, prevention and treatment, and medical information regarding biomarker testing relating thereto
Owner
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
Prior registrations
Prosecution history
- 08 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Oct 2025 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 16 May 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 May 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Apr 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Apr 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Apr 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Oct 2019 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Oct 2019 — NON-FINAL ACTION E-MAILED
- 22 Oct 2019 — SU - NON-FINAL ACTION - WRITTEN